@article{8467b2c728f44b85b66f378ab7591b97,
title = "Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease.",
author = "Chan, {W. C.} and G. Elmberger and Lozano, {M. D.} and W. Sanger and Weisenburger, {D. D.}",
note = "Funding Information: efficient amplification of the NPM/ALK fusion message. Another possibility is that there are fundamental differences between the patient populations. Either the diagnostic criteria for Hodgkin{\textquoteright}s disease differ between the studies or there is a fundamental difference between Hodgkin{\textquoteright}s disease in Europe and North America. Whatever the ultimate reasons for the differences, results suggest that t(2;5) is rarely if ever detected in cases of Hodgkin{\textquoteright}s disease, and, furthermore, support the notion that Hodgkin{\textquoteright}s disease and t(2;5)-containing large-cell lymphoma distinct clinicopathological entities. This work was supported in part by NIH grants CA-01429 (JRD)j CA-50341 (LMW), Cancer Center Core Grant CA-21765, American Cancer Society Clinical Oncology Career Development Award 93-38 (ML), and by the American Lebanese Syrian Associated Charities of St Jude Children{\textquoteright}s Research Hospital.",
year = "1995",
month = apr,
day = "8",
language = "English (US)",
volume = "345",
pages = "921",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8954",
}